Slomovitz BM - Search Results

1

Incidental power morcellation of malignancy: a retrospective cohort study.

Graebe K, Garcia-Soto A, Aziz M, Valarezo V, Heller PB, Tchabo N, Tobias DH, Salamon C, Ramieri J, Dise C, Slomovitz BM. Graebe K, et al. Among authors: slomovitz bm. Gynecol Oncol. 2015 Feb;136(2):274-7. doi: 10.1016/j.ygyno.2014.11.018. Epub 2014 Nov 26. Gynecol Oncol. 2015. PMID: 25740603

2

Treatment options for molecular subtypes of endometrial cancer in 2023.

Karpel HC, Slomovitz B, Coleman RL, Pothuri B. Karpel HC, et al. Curr Opin Obstet Gynecol. 2023 Jun 1;35(3):270-278. doi: 10.1097/GCO.0000000000000855. Epub 2023 Mar 20. Curr Opin Obstet Gynecol. 2023. PMID: 36943683 Review.

3

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab.

Colombo N, Lorusso D, Monk BJ, Slomovitz B, Hasegawa K, Nogueira-Rodrigues A, Zale M, Okpara CE, Barresi G, McKenzie J, Makker V. Colombo N, et al. Oncologist. 2024 Jan 5;29(1):25-35. doi: 10.1093/oncolo/oyad201. Oncologist. 2024. PMID: 37523661 Free PMC article.

4

Low-grade serous ovarian cancer: expert consensus report on the state of the science.

Grisham RN, Slomovitz BM, Andrews N, Banerjee S, Brown J, Carey MS, Chui H, Coleman RL, Fader AN, Gaillard S, Gourley C, Sood AK, Monk BJ, Moore KN, Ray-Coquard I, Shih IM, Westin SN, Wong KK, Gershenson DM. Grisham RN, et al. Among authors: slomovitz bm. Int J Gynecol Cancer. 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610. Int J Gynecol Cancer. 2023. PMID: 37591609 Free PMC article.

5

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2003 Dec;91(3):463-9. doi: 10.1016/j.ygyno.2003.08.018. Gynecol Oncol. 2003. PMID: 14675663 Review.

6

Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.

Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Soliman PT, et al. Among authors: slomovitz bm. Gynecol Oncol. 2004 Aug;94(2):456-62. doi: 10.1016/j.ygyno.2004.05.006. Gynecol Oncol. 2004. PMID: 15297188 Review.

7

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2004 Oct;95(1):32-6. doi: 10.1016/j.ygyno.2004.06.052. Gynecol Oncol. 2004. PMID: 15385107

8

Practice patterns of SGO members for stage IIIA endometrial cancer.

Lee CM, Slomovitz BM, Greer M, Sharma S, Gregurich MA, Burke T, Lu KH, Ramondetta LM. Lee CM, et al. Among authors: slomovitz bm. Gynecol Oncol. 2005 Jul;98(1):77-83. doi: 10.1016/j.ygyno.2005.03.033. Gynecol Oncol. 2005. PMID: 15907988

9

Endometrial cancer in young, normal-weight women.

Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Schmeler KM, et al. Among authors: slomovitz bm. Gynecol Oncol. 2005 Nov;99(2):388-92. doi: 10.1016/j.ygyno.2005.06.029. Epub 2005 Jul 26. Gynecol Oncol. 2005. PMID: 16051336

10

The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).

Dietrich CS 3rd, Modesitt SC, DePriest PD, Ueland FR, Wilder J, Reedy MB, Pavlik EJ, Kryscio R, Cibull M, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins RV, Merritt W, Hunter J, Puls L, Gehrig P, van Nagell JR Jr. Dietrich CS 3rd, et al. Gynecol Oncol. 2005 Dec;99(3):557-63. doi: 10.1016/j.ygyno.2005.07.104. Epub 2005 Sep 8. Gynecol Oncol. 2005. PMID: 16154185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page